Mark W. Logue, PhD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

My research involves the use of computational tools to search the human genome for genetic variants influencing risk of psychiatric and neurological disorders including panic disorder, post-traumatic stress disorder, and Alzheimer’s disease. The genetics of these traits is complex, as multiple genes interact with environmental factors to determine an individual’s risk. When studying psychiatric traits, this complexity is compounded because psychiatric disorders are not distinct at the genetic level. For example, genetic variants that increase risk of developing panic disorder may also predispose an individual to bipolar disorder or phobias. To unravel this complexity, information must be integrated from a variety of sources, including families with a multiple affected individuals, large case-control study samples, and samples from different ancestral populations. The type of genetic data that can be examined is similarly diverse and can include microsatellite markers, single nucleotide polymorphisms, and base-pair level sequence data. By leveraging these multiple sources of data, and by using analysis methods that allow for this complexity at both the genetic and trait level, the presence of disease can be correlated with variants across multiple genes. The identification of these variants can implicate new biological systems or molecular pathways which are disrupted, potentially resulting in the development of new biomarkers of disease, new treatments, or personalized therapies based on a patient’s genetic profile.

Publications

  • Published 10/28/2026

    Uffelmann E, Wightman DP, Bahrami S, Shadrin AA, Fominykh V, Ojima T, Jiang C, Benner C, Moreno E, Campos AI, Thomassen JQ, Minois-Genin E, Wu HM, Walters GB, Sherva R, Lin T, Wang X, Bryois J, Krebs K, Schipper M, Narita A, Serretti A, Simonsen AH, van Seumeren AL, Corbett A, Knapskog AB, Hartmann AM, den Braber A, van Harten AC, Harder A, Rongve A, Madsen BO, Tijms BM, Aagaard B, Lichtwarck B, Kirsebom BE, Creese B, Reynolds CA, Hägg S, Karlsson IK, Erikstrup C, Mikkelsen C, Ballard C, Aarsland D, Shigemizu D, Rujescu D, Gudbjartsson D, Aakhus E, Sørensen E, Stordal E, Duits FH, Wolters FJ, Blanc F, Biessels GJ, Selbæk G, Bråthen G, Tamiya G, Waldemar G, Seelaar H, Eyjolfsdottir H, Holstege H, Bundgaard H, Zetterberg H, Ullum H, Giegling I, Skoog I, Medbøen IT, Saltvedt I, Rektorova I, Gaziano JM, Haavik J, Hjerling-Leffler J, Luo J, Snaedal J, Vijverberg EGB, Sealock JM, Blennow K, Nordengen K, Persson K, Scheffler K, Matsuda K, Ozaki K, Pihlstrøm L, Athanasiu L, Pålhaugen L, Hulsman M, Waern M, Averina M, Wettergreen M, Moksnes MR, Huisman M, Yamamoto M, Toft M, Panizzon MS, Topholm Bruun M, Ghanbari M, Franc M, Pedersen NL, Bell NY, Tesi N, Pedersen OB, Frei O, Bousiges O, Svenningsson P, Visser PJ, Li QS, Hauger R, Zhang R, Namba S, Sando SB, Kern S, Djurovic S, Thordardottir S, Phung TN, Truelsen T, Werge T, Hansen TF, Kyosaka T, Engstad T, Fladby T, Merritt V, Bergh S, van der Flier WM, Wang R, Stahl EA, Hooli B, Davis LK, Logue MW, Lehto K, Zettergren A, Brumpton BM, Zeng J, Visscher PM, O'Reilly PF, Mahajan A, Ferreira M, Okada Y, van der Lee SJ, Ostrowski SR, Frikke-Schmidt R, Stefansson H, Heilbron K, Andreassen OA, Posthuma D. Alzheimer's disease genetics converges on microglial and neuronal dysregulation. Nature. 2026 Oct 28. PMID: 42951976.

    Read at: PubMed

  • Published 10/22/2026

    Wolf EJ, Zhang R, Logue MW, Zhao X, Harrington KM, Miller MW, Gaziano JM, Pereira AC. Replication of claudin-5 epigenetics in association with PTSD severity in the VA Million Veteran Program. Psychiatry Res. 2026 Oct 22; 367:117550. PMID: 42956656.

    Read at: PubMed

  • Published 9/20/2026

    Ma P, Zhou J, Cheng Y, McGeary JE, Taveira TH, Ahmed A, Wu WC, Zamrini E, Dugger BN, Sevilla LNC, Nations JA, Shao Y, Yin Y, Tsuang DW, Logue MW, Ayandeh S, Faselis C, Nelson SJ, Zeng-Treitler Q. Varenicline as a Repurposable Drug Candidate for ADRD Prevention. medRxiv. 2026 Sep 20. PMID: 42779913.

    Read at: PubMed

  • Published 8/27/2026

    Kurniansyah N, Tasaki S, Rehman H, Zhu C, Farrell J, Sherva R, Hauger R, Merritt VC, Panizzon M, Zhang R, Gaziano JM, Gim J, Lee K, Lee DY, Nho K, Vialle RA, Mukherjee S, Trittschuh EH, Lee AJ, Brickman AM, Cruchaga C, Risacher S, Greve DN, Crane P, Martin E, Bush WS, Mayeux R, Haines JL, Pericak-Vance MA, Logue M, Bennett DA, Barnes LL, Saykin A, Hohman T, Wang LS, Schellenberg GD, Ang TFA, Au R, Mez J, Lunetta KL, Zhang X, Farrer LA. A multiancestry polygenic risk score for Alzheimer's disease is associated with cognitive decline and neuropathological hallmarks in diverse populations. Nat Genet. 2026 Sep; 58(9):2141-2151. PMID: 42661068.

    Read at: PubMed

  • Published 7/16/2026

    Lopez FV, Gillis M, Lee S, Sakamoto MS, Zhang R, Sherva R, Logue MW, Merritt VC. Curation of Mini Mental State Examination (MMSE) Scores in the VA Million Veteran Program (MVP): Applications for Cognitive Aging Research. medRxiv. 2026 Jul 16. PMID: 42528566.

    Read at: PubMed

Other Positions

  • Professor, Biostatistics
    Boston University School of Public Health
  • Investigator
    Framingham Heart Study
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University
  • Statistician, National Center for PTSD
    VA Boston Healthcare System
  • Member, Genome Science Institute
    Boston University

Education

  • University of Iowa, PhD
  • University of Iowa, MS
  • University of Oregon, BS